Official UK procurement notice
HIV Medicines · UK public procurement notice
Authority: The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)·Consortium: 2 public authorities
What is being bought2 lots · detail below
Published requirement descriptionSupply of HIV Medicines to NHS Scotland
CPV: Pharmaceutical products
How this framework works
From the published notice- Places
- up to 15 suppliers · 9 bids on the busiest of 2 lots (0.6 per place) · 14 appointed
Lots and requirements (2)Procurement structure
2 lots · all with a published value · same evaluation weights on every lotLot #1Generic HIV MedicinesCancelledRenewalPublished value£6,490,000
Supply of generic HIV medicines to NHS Scotland. The Authority awards this Lot as a ranked multi-supplier framework per product line to a maximum of four (4) Framework Participants.
Lot #2Branded HIV MedicinesCancelledRenewalPublished value£83,200,000
Supply of branded HIV medicines to NHS Scotland. The Authority awards this Lot as a single supplier framework per product line.
NOTE: Biktarvy and Genvoya are awarded as unranked multi supplier framework agreements to a maximum of two (2) Framework Participants.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Logistics: 5%
- price: 95%
Published award criteria (2)
- Logistics: 5
- Price: 95
- Suitability
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015
- Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement.
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement should be included in the Qualificat…
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “HIV Medicines” is a framework: the contest is a place on its panel, up to 15 suppliers, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 5 Jan 2026, 15:22 GMT
- Last source update
- 7 May 2026, 15:32 BST
- Award evaluation window
- 4 Feb 2026 – …
- Authority reference
NP43326- FTS notice number
2026/S 000-042069- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-05ff84Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Publisher note: The estimated value(s) referred to in Section II.1.5 and within all Lot cover(s) the twenty four (24) month contract duration and the twenty four (24) month extension period of the framework agreement. (SC Ref:829345)
How it was run
Official notice- Appointment period ends
- 4 Feb 2026, 12:00 GMT
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 4 Feb 2026, 12:00 GMT
Timeline
4 Feb 2026 → 7 May 2026 · 3 dates- Admission / appointment period ends264 days ago · period end, not a bid countdown4 Feb 2026, 12:00 GMT
- Bids opened264 days ago4 Feb 2026, 12:00 GMT
- Notice published172 days ago7 May 2026, 15:32 BST
Notice history
2 events · 2 releases on Find a Tender · since 7 May 2026- Status changed to complete7 May 2026, 15:32 BST
- Buyer details updated7 May 2026, 15:32 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast2 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Generic HIV Medicines
- Signed
- 17 Apr 2026
- Value
- £3,636,988
- Status
- active
Branded HIV Medicines
- Signed
- 17 Apr 2026
- Value
- £79,068,428
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Generic HIV Medicines | 9bids · 9 electronic · 9 from abroad | 0 | — | — |
| 2 · Branded HIV Medicines | 5bids · 5 electronic · 5 from abroad | 0 | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeConsortium members and other public bodies
- The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Contracting authorityCentral purchasing bodyBody governed by public lawHealth
Dispute resolution & review bodies
- Sheriff Court HouseReview body
Framework contractors & participating bidders
14 commercial parties on the notice- Amarox LimitedFramework contractor
- CST Pharma LtdFramework contractor
- Dr Reddy's Laboratories (UK) LtdFramework contractor
- Gilead Sciences LtdFramework contractor
- Glenmark Pharmaceuticals Europe LtdFramework contractor
- Janssen-Cilag LtdFramework contractor
- Lupin Healthcare UK LtdFramework contractor
- MSN LabsFramework contractor
- Merck Sharp & Dohme UK LtdFramework contractor
- Milpharm LimitedFramework contractor
Show 4 more suppliers
- Orifarm UK LtdFramework contractor
- Sun Pharma UK LtdFramework contractor
- Viatris UK Healthcare LtdFramework contractor
- ViiV Healthcare UK LtdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.